Possible roles of insulin-like growth factor in regulation of physiological and pathophysiological liver growth.

• BACKGROUND/AIMS: Almost all circulating insulin-like growth factor-1 (IGF-1) is produced and secreted from the liver. However, the possible role of IGF-1 in local regulation of liver functions including liver growth is unclear. In the present study, we investigated the role of IGF-1 on liver growth in vivo and in hepatic stellate cell function in vitro. RESULTS: Liver-specific knock-out of the IGF-1 gene by use of the cre-loxP system caused enhanced liver growth, possibly reflecting increased growth hormone (GH) secretion due to decreased negative feedback by IGF-1. Studies on cultured rat hepatic stellate cells (HSC) showed that IGF-1 and hepatocyte-conditioned medium (PCcM) time- and dose-dependently increased hepatocyte growth factor (HGF) mRNA and HGF immunoreactivity. IGF-1 and PCcM also enhanced DNA synthesis in the HSC cultures. The PCcM did not contain bioactive IGF-1 and was also able to stimulate proliferation when prepared under serum- and hormone-free conditions. CONCLUSION: In vivo results show that IGF-1 is not essential for normal growth of the intact liver. The in vitro results indicate that both IGF-1 and IGF- 1-independent factor(s) from hepatocytes can stimulate HGF production by HSC. It remains to be investigated whether these effects are of importance for liver regeneration or pathological conditions.

Nyckelord

Animals

Cell Division

physiology

Culture Media

Conditioned

pharmacology

DNA

biosynthesis

Hepatocyte Growth Factor

biosynthesis

genetics

Hepatocytes

cytology

pathology

Liver

cytology

growth & development

metabolism

pathology

Liver Diseases

physiopathology

Mice

Mice

Knockout

genetics

Mitogens

pharmacology

Somatomedins

deficiency

physiology

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)